https://pipelinereview.com/velicept-therapeutics-initiates-first-of-two-phase-2b-dose-ranging-studies-of-solabegron-in-patients-with-overactive-bladder-oab-finalizes-novel-once-daily-formulation-and-receives-u-s-patent-covering/